Executive Summary
Six filings are in scope for this India MCA Insolvency & Restructuring digest, though the enriched fields the brief describes (period-over-period comparisons, insider trading, capital allocation, forward guidance, transaction valuations) are essentially absent from the filing summaries provided.
None of the six reports contain revenue, margin, debt, insider, dividend, or valuation figures, so no quantitative portfolio-level trend can be honestly derived; the synthesis below is qualitative and procedural. The dominant theme is distressed-company process risk: two companies (Siti Networks and Gangotri Textiles) carry the highest materiality (9/10) and negative sentiment, with a new Resolution Professional appointment at Siti after a prior RP's registration cancellation and a Section 10 self-initiated CIRP at Gangotri with board powers suspended. Two filings show live restructuring pathways (Bajaj Healthcare's approved acquisition of Genrx Pharmaceuticals in liquidation; VAS Infrastructure's CIRP timetable extended by one week at each stage). Polycab's NCLAT appeal and AGS Transact's rescheduled CoC meeting are procedural, mid-materiality items. Actionable near-term dates are October 15 (AGS CoC meeting, Polycab NCLAT hearing) and October 20-23 (VAS EoI deadline and provisional applicant list), with the Siti hearing on December 3 later in the window.
Materiality, sentiment, and priority are scored by Gunpowder’s analysis pipeline. How we score filings →
Filing types in this digest: Insolvency
Tracking the trend? Catch up on the prior India MCA Insolvency Liquidation Filings digest from October 13, 2026.
Investment Signals (7)
- Bajaj Healthcare ↓ (BULLISH)▲
NCLT Mumbai approved acquisition of Genrx Pharmaceuticals (in liquidation) on a going-concern basis, making it a wholly owned subsidiary; no consideration or valuation disclosed, so accretion cannot be assessed
- VAS Infrastructure ↓ (NEUTRAL)▲
CIRP is continuing rather than stalling; EoI and resolution plan deadlines extended by one week (to Oct 20 and Nov 30), indicating active prospective-applicant interest
- AGS Transact Technologies ↓ (NEUTRAL)▲
19th CoC meeting rescheduled to Oct 15, 2026 at 2:00 p.m.; the procedural change is routine and carries no disclosed outcome signal
- Polycab India ↓ (NEUTRAL)▲
NCLAT granted early listing of Asier Metals' appeal, now set for Oct 15, 2026; this is the fourth related intimation in ten days, which suggests an escalating procedural track but no quantified financial impact
- Siti Networks ↓ (NEUTRAL)▲
New RP (Trupalkumar Patel) approved by Joint Lender Meeting with 72% voting, indicating lender consensus on the replacement after the prior RP's IBBI registration cancellation
- Gangotri Textiles ↓ (BEARISH)▲
Section 10 self-initiated CIRP admitted by NCLT Chennai with IRP G. Gunasekaran; board powers suspended from Aug 7, 2026, signalling full control transfer to the IRP
- Siti Networks ↓ (BEARISH)▲
Lender-led RP replacement follows IBBI disciplinary action against the prior RP (order dated Aug 6, effective Sep 6), a governance red flag on the process integrity
Risk Flags (8)
- Siti Networks/Process Integrity↓ [HIGH RISK]▼
Prior RP's registration cancelled by IBBI (order IBBI/DC/338/2026); a replacement RP was appointed via NCLT order of Sep 28 (received Oct 12), with the next hearing on Dec 3, 2026 and the new RP's AFA valid only to Dec 31, 2026
- Gangotri Textiles/Governance Control↓ [HIGH RISK]▼
All board and committee powers suspended since Aug 7, 2026; compliance officer changed from Manoj Kumar Tibrewal to G. Gunasekaran, indicating management has been displaced entirely
- Gangotri Textiles/Information Gap↓ [HIGH RISK]▼
The filing discloses no debt, asset, or revenue figures, so creditor recovery prospects cannot be estimated from the disclosure
- Siti Networks/Lender Exposure↓ [ELEVATED RISK]▼
IndusInd Bank is the applicant, indicating a secured-lender enforcement route with a timeline that depends on hearings running into late 2026
- VAS Infrastructure/Timeline Slippage↓ [ELEVATED RISK]▼
Every resolution stage has slipped by one week (EoI Oct 13 to Oct 20; plans Nov 23 to Nov 30), and further extensions remain possible if applicant requests continue
- Bajaj Healthcare/Transaction Opacity↓ [MEDIUM RISK]▼
NCLT order transforms Genrx into a subsidiary, but no consideration, liabilities assumed, or integration timeline is disclosed, leaving investors unable to judge balance-sheet impact
- Bajaj Healthcare/Trading Restriction↓ [MEDIUM RISK]▼
Trading window for designated persons remains closed (per Sep 23 disclosure), signalling undisclosed material information in progress
- Polycab India/Litigation Escalation↓ [MEDIUM RISK]▼
Fourth related intimation in roughly ten days, with an NCLAT hearing on Oct 15; an adverse appellate outcome could carry unquantified financial exposure to a large listed company
Opportunities (6)
- Bajaj Healthcare/Genrx Acquisition↓ (OPPORTUNITY)◆
Going-concern acquisition of a liquidated pharma entity can add capacity and assets at possibly distressed prices; the Oct 13 NCLT order makes the transaction effective until further orders
- VAS Infrastructure/Resolution Plan Pipeline↓ (OPPORTUNITY)◆
Extended EoI window (Oct 20), provisional applicant list (Oct 23), and information memorandum (Oct 31) create a near-term entry point for distressed-asset investors monitoring the applicant list
- Polycab India/NCLAT Outcome↓ (OPPORTUNITY)◆
A hearing on Oct 15 may resolve the Asier Metals appeal; a favourable ruling would remove a tail risk for a fundamentally strong large-cap
- AGS Transact/CoC Outcome↓ (OPPORTUNITY)◆
The Oct 15 CoC meeting is a near-term catalyst where creditor decisions could clarify the resolution route for a listed fintech payments company
- Siti Networks/Resolution Route Clarity↓ (OPPORTUNITY)◆
With a lender-approved RP and a Dec 3 hearing, the restructuring path is becoming more defined; investors with a view on cable and broadband distressed assets can prepare for an information memorandum
- Gangotri Textiles/Creditor Recovery Setup↓ (OPPORTUNITY)◆
The Section 10 CIRP admission gives a formal claims and resolution process; creditors and distressed-debt buyers can track claims verification once the IRP issues the public announcement
Sector Themes (5)
- Procedural Timeline Slippage in CIRP◆
Two processes show schedule changes: VAS Infrastructure extended every stage by one week, and AGS Transact rescheduled its CoC meeting; this pattern points to routine slippage as applicant and creditor engagement works through the process [IMPLICATION: budget for extended timelines when modelling recovery dates]
- Governance Failures in Insolvency Professional Oversight◆
The Siti Networks RP cancellation by IBBI (disciplinary order Aug 6, effective Sep 6) is a notable regulator action; combined with the Gangotri board suspension, this reflects displacement of management and oversight scrutiny [IMPLICATION: process-integrity risk warrants extra diligence on RP track record]
- Mix of Self-Initiated and Creditor-Initiated Insolvency◆
Gangotri (Section 10, self-filed) and Siti (lender-applied, Section 7) show both routes; self-filings typically carry different creditor dynamics and recovery expectations [IMPLICATION: distinguish the petition route when assessing recovery]
- Liquidation-to-Acquisition Pathway Gaining Traction◆
Bajaj Healthcare's acquisition of a company in liquidation on a going-concern basis shows that NCLT-approved asset transfers can preserve value for acquirers [IMPLICATION: watch for similar going-concern transfers as an exit route for stressed assets]
- Mid-Cap and Large-Cap Exposure to Insolvency Litigation◆
Polycab (large-cap) facing an operational-creditor appeal shows that insolvency litigation reaches established companies, not only stressed names [IMPLICATION: monitor counterparty insolvency proceedings for contingent liabilities]
Watch List (6)
-
Rescheduled to Thu, Oct 15, 2026 at 2:00 p.m. (video conference); watch for resolution-route decisions and any change to resolution plan timing
-
Hearing scheduled Oct 15, 2026 at the NCLAT Principal Bench, New Delhi; any adverse ruling would need disclosure under Regulation 30
-
Provisional applicant list Oct 23, objections Oct 28, final list Oct 30, information memorandum and RP call Oct 31, 2026; further extensions possible
-
Listed for Dec 3, 2026; the new RP's AFA expires Dec 31, 2026, so renewal or extension decisions fall in this window
-
Watch for the consideration terms, liabilities assumed, and the trading-window reopening that would follow implementation of the Oct 13 NCLT order
-
Watch for the public announcement inviting claims, the first committee of creditors meeting, and any disclosure of asset and debt values
Filing Analyses
(6)
14-10-2026
VAS Infrastructure Limited, under Corporate Insolvency Resolution Process (CIRP) with Mr. Bimal Kumar Agarwal as Resolution Professional, has published a corrigendum to its Form G Expression of Interest, extending all key resolution timelines. The last date for receipt of EoI moves from October 13, 2026 to October 20, 2026, and the last date for submission of resolution plans moves from November 23, 2026 to November 30, 2026. The extension follows requests from prospective applicants, so the process is continuing rather than stalling, but the timetable has slipped by one week at each stage.
- · Revised timeline: provisional list of prospective resolution applicants moves to October 23, 2026; objections due October 28, 2026; final list October 30, 2026; information memorandum and request for resolution plans issued October 31, 2026
- · The corrigendum was published in Free Press Journal (English) and Navshakti (Marathi), Mumbai editions; the company states it is available on its website and the IBBI website
- · The NCLT Mumbai Bench order approving the RP appointment is IA No. 3523 of 2026 in C.P. (IB) No. 314/MB/2023, dated August 13, 2026
- · Filing date discrepancy: the 'date of the event' in the table is stated as September 14, 2026, while the corrigendum itself and the letter reference publication on October 14, 2026
- · Expression of Interest submission email: cirp@vasinfra.com (letter) versus cirp@vasinfra.com in the table; the asset in the sale is a real estate project in Borivali West, Mumbai
14-10-2026
Bajaj Healthcare Limited disclosed that the Hon'ble NCLT Mumbai Bench, by order dated October 13, 2026, approved the acquisition of Genrx Pharmaceuticals Private Limited (in Liquidation) on a going concern basis, to become a wholly owned subsidiary subject to implementation of the NCLT order terms. The order is effective from October 13, 2026 until further orders, and the company's trading window remains closed for designated persons per the September 23, 2026 disclosure. The filing does not disclose any transaction value, consideration, or financial figures.
- · Order dated October 13, 2026 by NCLT Mumbai Bench; company downloaded it from the NCLT website on October 13, 2026
- · Genrx Pharmaceuticals will become a Wholly Owned Subsidiary of Bajaj Healthcare, subject to implementation of NCLT order terms
- · Trading window for designated persons and immediate relatives remains closed, per the September 23, 2026 disclosure
- · No aberrations, non-compliances, penalties, or restrictions were identified by the authority
14-10-2026
SITI Networks Limited disclosed, via a Regulation 30 filing dated October 14, 2026, that the Hon'ble NCLT Mumbai Bench, by order dated September 28, 2026 (received October 12, 2026), appointed Mr. Trupalkumar Patel as Resolution Professional under Section 7 of the IBC, 2016, on an application by IndusInd Bank Ltd. The appointment followed the IBBI's cancellation of the prior RP's registration (disciplinary order dated August 6, 2026, effective September 6, 2026) and a Joint Lender Meeting on September 16, 2026, which approved the new RP with 72% voting. The matter is listed for next hearing on December 3, 2026.
- · The prior Resolution Professional's registration was cancelled by IBBI disciplinary order No. IBBI/DC/338/2026 dated August 6, 2026, which became effective September 6, 2026
- · The Joint Lender Meeting held September 16, 2026 approved the new RP's appointment, with the new RP's authorization for exercise (AFA) valid up to December 31, 2026
- · The matter is listed for next hearing on December 3, 2026
- · The filing is a continuation of the company's earlier disclosure dated October 13, 2026
14-10-2026
AGS Transact Technologies Limited, currently under the Corporate Insolvency Resolution Process (CIRP), has rescheduled its 19th Committee of Creditors (CoC) meeting to Thursday, 15 October 2026 at 2:00 p.m. via video conferencing. The disclosure is made under Regulation 30 of the SEBI (LODR) Regulations, 2015, and is issued by the Deemed Resolution Professional, Brijendra Kumar Mishra.
- · The 19th CoC meeting was rescheduled to Thursday, 15 October 2026 at 2:00 p.m. via video conferencing
- · Filing reference: IRP/AGS/M/26-27/1792, dated 14 October 2026
- · BSE Scrip Code: 543451; NSE Symbol: AGSTRA
- · Resolution Professional's IBBI Registration No: IBBI/IPA-002/IP-N00109/2017-2018/10257; AFA valid till 31 December 2026
14-10-2026
Polycab India Limited disclosed under Regulation 30 of SEBI (LODR) Regulations, 2015 an update on an appeal filed by Asier Metals Private Limited against the company, which was listed before the Hon'ble NCLAT, Principal Bench, New Delhi. The NCLAT granted a request for early listing, and the appeal is now scheduled to be heard on October 15, 2026. The filing is procedural in nature and includes no quantified financial impact.
- · The appeal was originally listed for hearing on October 26, 2026, and was advanced to October 14, 2026 for an early hearing request, with the hearing now set for October 15, 2026.
- · This is the fourth related intimation, following earlier disclosures dated October 07, 2026, October 08, 2026 and October 09, 2026.
14-10-2026
Gangotri Textiles Ltd disclosed that the National Company Law Tribunal (NCLT), Chennai, admitted the company's own Section 10 petition for Corporate Insolvency Resolution Process (CIRP) by an order dated 7 August 2026, appointing Mr. G. Gunasekaran as Interim Resolution Professional (IRP). Under the order, the powers of the Board of Directors and Committees stand suspended from 7 August 2026, and Mr. Gunasekaran replaces Mr. Manoj Kumar Tibrewal as Compliance Officer. The filing contains no financial figures on debt, assets, or revenue.
- · Insolvency petition filed under Section 10 of the IBC, case reference CP(IB) 310/CHE/2025, before NCLT Chennai
- · Mr. G. Gunasekaran is registered with the IBBI under Regn No. IBBI/IPA-001/IP-P00681/2017-2018/11178
- · Board and committee powers suspended with effect from 7 August 2026, with control transferred to the IRP
- · Filing dated 14 October 2026 was made under Regulation 30 of SEBI LODR Regulations, 2015, with a 7-week lag between the order date and disclosure
Get daily alerts with 7 investment signals, 8 risk alerts, 6 opportunities and full AI analysis of all 6 filings
₹500/mo after a 14-day free trial — no credit card required. See pricing or explore intelligence streams.
More from: India MCA Insolvency Liquidation Filings
October 12, 2026
India MCA Insolvency Liquidation Filings — October 12, 2026
October 10, 2026
India MCA Insolvency Liquidation Filings — October 10, 2026
October 09, 2026
India MCA Insolvency Liquidation Filings — October 09, 2026
October 08, 2026
India MCA Insolvency Liquidation Filings — October 08, 2026
🇮🇳 More from India
View all →October 15, 2026
India Upcoming Corporate Actions BSE NSE — October 15, 2026
India Upcoming Corporate Actions BSE NSE
October 15, 2026
India Quarterly Results BSE NSE Announcements — October 15, 2026
India Quarterly Results BSE NSE Announcements
October 15, 2026
India Pre-Market Regulatory Roundup — October 15, 2026
India Pre-Market Regulatory Roundup
October 15, 2026
India RBI Monetary Policy Repo Rate Decisions — October 15, 2026
India RBI Monetary Policy Repo Rate Decisions